Literature DB >> 20841969

Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine.

Melina C Ortigas, James A Bourgeois, Andrea Schneider, John Olichney, Danh V Nguyen, Jennifer B Cogswell, Deborah A Hall, Randi J Hagerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20841969      PMCID： PMC4022473          DOI： 10.1097/JCP.0b013e3181f1d10a

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  19 in total

1.  Standardization of a neuromotor test battery: the CATSYS system.

Authors:  C Després; D Lamoureux; A Beuter
Journal:  Neurotoxicology       Date:  2000-10       Impact factor: 4.294

Review 2.  The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.

Authors:  J L Cummings
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

Review 3.  Evaluation of memantine for neuroprotection in dementia.

Authors:  K K Jain
Journal:  Expert Opin Investig Drugs       Date:  2000-06       Impact factor: 6.206

4.  Word repetition in amnesia. Electrophysiological measures of impaired and spared memory.

Authors:  J M Olichney; C Van Petten; K A Paller; D P Salmon; V J Iragui; M Kutas
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

5.  Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells.

Authors:  Dolores Garcia Arocena; Christine K Iwahashi; Nelly Won; Alexandra Beilina; Anna L Ludwig; Flora Tassone; Philip H Schwartz; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2005-10-20       Impact factor: 6.150

6.  Evidence relating human verbal memory to hippocampal N-methyl-D-aspartate receptors.

Authors:  T Grunwald; H Beck; K Lehnertz; I Blümcke; N Pezer; M Kurthen; G Fernández; D Van Roost; H J Heinze; M Kutas; C E Elger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

7.  Prevalence of disorders of executive cognitive functioning among the elderly: findings from the San Luis Valley Health and Aging Study.

Authors:  Jim Grigsby; Kaye Kaye; Susan M Shetterly; Judith Baxter; Nora E Morgenstern; Richard F Hamman
Journal:  Neuroepidemiology       Date:  2002 Sep-Oct       Impact factor: 3.282

Review 8.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

9.  Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates.

Authors:  Sébastien Jacquemont; Randi J Hagerman; Maureen Leehey; Jim Grigsby; Lin Zhang; James A Brunberg; Claudia Greco; Vincent Des Portes; Tristan Jardini; Richard Levine; Elizabeth Berry-Kravis; W Ted Brown; Stephane Schaeffer; John Kissel; Flora Tassone; Paul J Hagerman
Journal:  Am J Hum Genet       Date:  2003-03-12       Impact factor: 11.025

10.  Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee.

Authors:  A Maddalena; C S Richards; M J McGinniss; A Brothman; R J Desnick; R E Grier; B Hirsch; P Jacky; G A McDowell; B Popovich; M Watson; D J Wolff
Journal:  Genet Med       Date:  2001 May-Jun       Impact factor: 8.822
View more
  16 in total

Review 1.  Fragile X-associated tremor/ataxia syndrome.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Ann N Y Acad Sci       Date:  2015-01-26       Impact factor: 5.691

2.  PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS.

Authors:  Andreea L Seritan; Melina Ortigas; Stefan Seritan; James A Bourgeois; Randi J Hagerman
Journal:  Curr Psychiatry Rev       Date:  2013

3.  Motor deficits on a ladder rung task in male and female adolescent and adult CGG knock-in mice.

Authors:  Michael R Hunsaker; Ramona E von Leden; Binh T Ta; Naomi J Goodrich-Hunsaker; Gloria Arque; Kyoungmi Kim; Rob Willemsen; Robert F Berman
Journal:  Behav Brain Res       Date:  2011-03-31       Impact factor: 3.332

4.  COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS.

Authors:  Andreea Seritan; Jennifer Cogswell; Jim Grigsby
Journal:  Curr Psychiatry Rev       Date:  2013-02

Review 5.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

Review 6.  Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Randi Hagerman; Paul Hagerman
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

7.  Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study.

Authors:  Jin-Chen Yang; Yu-Qiong Niu; Christa Simon; Andreea L Seritan; Lawrence Chen; Andrea Schneider; Shayan T Moghaddam; Paul J Hagerman; Randi J Hagerman; John M Olichney
Journal:  Neuropsychopharmacology       Date:  2014-05-29       Impact factor: 7.853

8.  Towards an Understanding of Neuropsychiatric Manifestations in Fragile X Premutation Carriers.

Authors:  Aaron D Besterman; Scott A Wilke; Tua-Elisabeth Mulligan; Stephen C Allison; Randi Hagerman; Andreea L Seritan; James A Bourgeois
Journal:  Future Neurol       Date:  2014-03

9.  Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Andreea L Seritan; Danh V Nguyen; Yi Mu; Flora Tassone; James A Bourgeois; Andrea Schneider; Jennifer B Cogswell; Kylee R Cook; Maureen A Leehey; Jim Grigsby; John M Olichney; Patrick E Adams; Wendi Legg; Lin Zhang; Paul J Hagerman; Randi J Hagerman
Journal:  J Clin Psychiatry       Date:  2014-03       Impact factor: 4.384

10.  Placebo Response in Fragile X-associated Tremor/Ataxia Syndrome.

Authors:  Emily J Hill; Christopher G Goetz; Glenn T Stebbins; Randi Hagerman; Bichun Ouyang; Deborah A Hall
Journal:  Mov Disord Clin Pract       Date:  2020-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.